“Weeding the Garden” with Radiation Allows ALK+ Lung Cancer Patients to Continue Crizotinib, Increasing Survival
University of Colorado Cancer CenterStudy: patients taking crizotinib for ALK+ non-small cell lung cancer may safely and durably use up to three courses of targeted radiation therapy to eradicate pockets of drug-resistant disease.